Veracyte Competitors and Similar CompaniesClear all

Veracyte's competitors and similar companies include Personalis, SOPHiA GENETICS, Caris Life Sciences, Castle Biosciences, Biodesix, Roka Bioscience, CardioDx, ID Genomics, MDxHealth and Curetis.
Veracyte
Veracyte
Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer.
Personalis
Personalis
Personalis is a biotechnology company that specializes in cancer genomics.
SOPHiA GENETICS
SOPHiA GENETICS
SOPHiA GENETICS is a healthcare technology company focused on establishing the practice of data-driven medicine.
Caris Life Sciences
Caris Life Sciences
Caris Life Sciences is a molecular science company that provides cancer care services.
Castle Biosciences
Castle Biosciences
Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers.
Biodesix
Biodesix
Biodesix is a company that provides data-driven diagnostic solutions.
Roka Bioscience
Roka Bioscience
Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market.
CardioDx
CardioDx
CardioDx is a company developing cardiovascular genomic diagnostics.
ID Genomics
ID Genomics
ID Genomics is a company offering microbial identification, typing, and genomic analysis services.
MDxHealth
MDxHealth
MDxHealth is a molecular diagnostics company that develops and commercializes tests for cancer and other urologic diseases diagnosis.
Curetis
Curetis
Curetis is a molecular diagnostic firm focused on the development and commercialization of tools for diagnosing severe infectious diseases.
Founding Date
Founding Date
2008
Founding Date
2011
Founding Date
2011
Founding Date
2008
Founding Date
2008
Founding Date
2005
Founding Date
2009
Founding Date
2003
Founding Date
2012
Founding Date
2003
Founding Date
2007
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Type
Private
Type
Private
Type
Public
Type
Subsidiary
Tags
Locations
Locations
South San Francisco, US HQ
Marseille, FR
Haifa, IL
Austin, US
San Diego, US
Locations
Fremont, US HQ
West Wickham, GB
Locations
Rolle, CH HQ
Bidart, FR
Boston, US
Locations
Irving, US HQ
Tokyo, JP
Basel, CH
Cambridge, US
Irving, US
New York, US
Phoenix, US
see more
Locations
Friendswood, US HQ
Phoenix, US
Locations
Boulder, US HQ
De Soto, US
Locations
Warren, US HQ
Locations
Redwood City, US HQ
Greensboro, US
Locations
Seattle, US HQ
Seattle, US
Locations
Herstal, BE HQ
Nijmegen, NL
Irvine, US
Plano, US
Locations
Holzgerlingen, DE HQ
Employees
Employees
8154% increase
Employees
22344% decrease
Employees
423
Employees
1,468
Employees
61013% increase
Employees
21711% decrease
Employees
225% increase
Employees
609% decrease
Employees
2
Employees
252
Employees
57
Valuation ($)
Valuation ($)
2.6 b
Valuation ($)
340.9 m
Valuation ($)
236.4 m
Valuation ($)
N/A
Valuation ($)
936.9 m
Valuation ($)
239.5 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
93.5 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$517.1m (FY, 2025)
Revenue (est.)
$69.6m (FY, 2025)
Revenue (est.)
$65.2m (FY, 2024)
Revenue (est.)
$812m (FY, 2025)
Revenue (est.)
$344.2m (FY, 2025)
Revenue (est.)
$88.5m (FY, 2025)
Revenue (est.)
$7.2m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$107.9m (FY, 2025)
Revenue (est.)
€1.4m (FY, 2018)
Cost of goods
Cost of goods
N/A
Cost of goods
$53.9m (FY, 2025)
Cost of goods
$17.7m (FY, 2024)
Cost of goods
N/A
Cost of goods
$71m (FY, 2025)
Cost of goods
N/A
Cost of goods
$8m (FY, 2016)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$36.1m (FY, 2025)
Cost of goods
€2m (FY, 2018)
Gross profit
Gross profit
$362.5m (FY, 2025)
Gross profit
$15.8m (FY, 2025)
Gross profit
$47.6m (FY, 2024)
Gross profit
N/A
Gross profit
$273.2m (FY, 2025)
Gross profit
N/A
Gross profit
($732k) (FY, 2016)
Gross profit
N/A
Gross profit
N/A
Gross profit
$71.8m (FY, 2025)
Gross profit
€138k (FY, 2018)
Net income
Net income
$66.4m (FY, 2025)
Net income
($81.3m) (FY, 2025)
Net income
($62.5m) (FY, 2024)
Net income
($68.1m) (FY, 2025)
Net income
($24.2m) (FY, 2025)
Net income
($35.3m) (FY, 2025)
Net income
($30.8m) (FY, 2016)
Net income
N/A
Net income
N/A
Net income
($33.5m) (FY, 2025)
Net income
(€23.7m) (FY, 2018)

Operating

Completed Clinical Studies to Date
Completed Clinical Studies to Date
50 (FY, 2020)
Completed Clinical Studies to Date
N/A
Completed Clinical Studies to Date
N/A
Completed Clinical Studies to Date
N/A
Completed Clinical Studies to Date
N/A
Completed Clinical Studies to Date
23 (Q2, 2020)
Completed Clinical Studies to Date
N/A
Completed Clinical Studies to Date
N/A
Completed Clinical Studies to Date
N/A
Completed Clinical Studies to Date
N/A
Completed Clinical Studies to Date
N/A
Customers
Customers
N/A
Customers
N/A
Customers
382 (FY, 2021)
Customers
N/A
Customers
N/A
Customers
N/A
Customers
N/A
Customers
N/A
Customers
N/A
Customers
1 k (FY, 2021)
Customers
N/A
Facility Space Leased, sq. ft.
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
42.6 k (FY, 2021)
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
61.5 k (FY, 2021)
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
12 (Q1, 2022)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
3 (Sep, 2022)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents Issued
Patents Issued
N/A
Patents Issued
16 (FY, 2021)
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
72 (FY, 2021)
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Peer-Reviewed Publications Published
Peer-Reviewed Publications Published
N/A
Peer-Reviewed Publications Published
N/A
Peer-Reviewed Publications Published
330 (FY, 2021)
Peer-Reviewed Publications Published
N/A
Peer-Reviewed Publications Published
N/A
Peer-Reviewed Publications Published
275 (Q2, 2020)
Peer-Reviewed Publications Published
N/A
Peer-Reviewed Publications Published
N/A
Peer-Reviewed Publications Published
N/A
Peer-Reviewed Publications Published
N/A
Peer-Reviewed Publications Published
N/A
Trademarks (US)
Trademarks (US)
N/A
Trademarks (US)
N/A
Trademarks (US)
9 (FY, 2021)
Trademarks (US)
N/A
Trademarks (US)
13 (FY, 2021)
Trademarks (US)
N/A
Trademarks (US)
N/A
Trademarks (US)
N/A
Trademarks (US)
N/A
Trademarks (US)
N/A
Trademarks (US)
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 17m (over 12 years ago)
Latest funding round
$ 22.5m (over 9 years ago)
Latest funding round
$ 3m (about 10 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 116.3m
Total funding raised
$ 75m
Total funding raised
$ 245.8m
Total funding raised
$ 1.1b
Total funding raised
$ 46.5m
Total funding raised
$ 98.2m
Total funding raised
$ 109.5m
Total funding raised
$ 311.3m
Total funding raised
$ 3m
Total funding raised
$ 1.1m
Total funding raised
$ 67.8m
For sources of this data, please see the company profile

View Company Profiles

Personalis
HQ
Fremont, US
Employees
223↓ 44% decrease

Personalis is a biotechnology company that specializes in cancer genomics.

View company
SOPHiA GENETICS
HQ
Rolle, CH
Employees
423

SOPHiA GENETICS is a healthcare technology company focused on establishing the practice of data-driven medicine.

View company
Caris Life Sciences
HQ
Irving, US
Employees
1,468

Caris Life Sciences is a molecular science company that provides cancer care services.

View company
Castle Biosciences
HQ
Friendswood, US
Employees
610↑ 13% increase

Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers.

View company